Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

US Patent 9757389 · Granted Sep 12, 2017

Estimated economic value: $650,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydroxyprogesterone caproate compositions and methods of use in preventing prete2025
Oral allopregnanolone compositions and methods of use2025
Oral allopregnanolone compositions and methods of use2025
Oral allopregnanolone compositions and methods of use2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy2025
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy2025
Composition and method for oral delivery of androgen prodrugs2025
Composition and method for oral delivery of androgen prodrugs2025
Oral testosterone therapy2025